Healio
Healio

OCTANe Ophthalmology Technology Forum
ByEhsan Sadri, MD, FACS
ByAnthony DeFino
Fact checked byChristine Klimanskis, ELS

Read more

June 15, 2023
3 min watch
Save

VIDEO: Panel discusses disruptive innovations in ophthalmology

ByEhsan Sadri, MD, FACS
ByAnthony DeFino
Fact checked byChristine Klimanskis, ELS

Key takeaways:

  • A panel at the Octane meeting focused on disruptive innovations in ophthalmology.
  • The Octane meeting fosters venture-based innovations.

NEWPORT BEACH, Calif. — In this Healio Video Perspective from Octane’s Ophthalmology Tech Forum, Ehsan Sadri, MD, FACS, discusses a panel that looked at the companies serving as disruptive innovators in eye care.

“Essentially, we were looking at what’s exciting and what’s the next step in our world. What are we looking at as ophthalmologists?” he said.

Topics covered in the panel included the work of companies such as Orasis Pharmaceuticals and Visus Therapeutics in the pharmaceutical presbyopia space as well as IOL innovations from Johnson & Johnson Vision.

Sources/Disclosures

Collapse
Source:

Sadri E, et al. Disruptive innovations. Presented at: Octane’s Ophthalmology Tech Forum; June 9, 2023; Newport Beach, California.

Disclosures: Sadri reports being a board member of Octane, co-founder of Visionary Ventures and an advisor for Ace Vision Group, Alcon, Centricity, Johnson & Johnson and Zeiss.

Read more about

ophthalmology
 

Related Content